Adam Schmucker

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

Susanne H.C. Baumeister, Joana Murad, Lillian Werner et al. · Cancer Immunology Research · 2018 · 325 citations · Full text

Pharmacy, Immunology, Oncology +17

RETRACTED: Autoimmunity as the Consequence of a Spontaneous Mutation in Rasgrp1

Katrin Layer, Guosheng Lin, Alessio Nencioni et al. · Immunity · 2003 · 73 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy

Joana Murad, Susanne H.C. Baumeister, Lillian Werner et al. · Cytotherapy · 2018 · 55 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

Sarah Nikiforow, Lillian Werner, Joana Murad et al. · Blood · 2016 · 40 citations

Medicine, Hematology, Oncology +17

Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression

Peter S. Burrage, Adam Schmucker, Yanqing Ren et al. · Arthritis Research & Therapy · 2008 · 26 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14